JESSICA FALCO: Open Payments
NPI 1508473059 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,357 in 82 payments from 14 companies in 2025. Trend: 2023 $790 · 2024 $1,559 · 2025 $1,357
Food & beverage: $1,357
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 49 | $508 |
| AOP Health US, LLC | 1 | $265 |
| Merck Sharp & Dohme LLC | 8 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $104 |
| BridgeBio Pharma, Inc. | 4 | $78 |
| SCPHARMACEUTICALS INC. | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| Lilly USA, LLC | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Esperion Therapeutics, Inc. | 1 | $27 |
Products named: LEQVIO, Rapiblyk, VERQUVO, JARDIANCE, Attruby, FUROSCIX, CAMZYOS, MOUNJARO.
Industry payments across NY — which companies pay providers there.
